Results of some of the surveys we have conducted during 2014:
Urinary Tract Infection (UTI) – Recurrent UTIs are still one of the world’s major health issues, causing not only suffering among patients but also putting significant pressure on the healthcare system. We at Wellspect are very much engaged in finding solutions to this problem; our vision is: “Safe, infection-free urinary catheter care”. Thanks to the commitment from our TellUs members, we gain better understanding of how catheter users experience this problem, a very important insight in our ongoing work on this issue.
The value of the catheter features – There is an ongoing debate about the different catheter types and features and what value they bring to those who use them. We at Wellspect wanted to share some light on this issue from the users perspective. We found out that the different catheter features do have value for the user (or mean something for the user). Read more
LoFric® effectiveness – Thanks to the commitment from our TellUs members, we increased our knowledge about the benefits that LoFric urinary catheters bring to our users - an important insight to have for further development of our services and products. The goal is to do better in the future.
Online habits – In today’s society, information is only a click away; the challenge is finding the right information. Thanks to the commitment from our TellUs members, we gain more knowledge about what urinary catheter users expect and wish to find on our website. The goal is to provide knowledge and services that better meet the needs of catheter users.
Accessories to help you catheterize – For some, accessories play an important role when performing intermittent self-catheterization. Thanks to the commitment from our TellUs members, we gain more understanding about what is important when using accessories when performing intermittent self-catheterization. The goal is to do better in the future.
Join the TellUs panel!
Choose a country/language.
LoFric® is the registered trademark of Wellspect HealthCare.